These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 8074133)

  • 1. Naloxone-induced activation of the hypothalamic-pituitary-adrenal axis in suspected central adrenal insufficiency.
    Blevins LS; Dobs AS; Wand GS
    Am J Med Sci; 1994 Sep; 308(3):167-70. PubMed ID: 8074133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M; Allolio B; Würth G; Winkelmann W
    J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man.
    Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
    J Clin Endocrinol Metab; 1993 Feb; 76(2):388-91. PubMed ID: 8381800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The low-dose ACTH test does not provide a useful assessment of the hypothalamic-pituitary-adrenal axis in secondary adrenal insufficiency.
    Suliman AM; Smith TP; Labib M; Fiad TM; McKenna TJ
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):533-9. PubMed ID: 11966747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the hypothalamic-pituitary-adrenal axis in children with leukemia before and after 6 weeks of high-dose glucocorticoid therapy.
    Kuperman H; Damiani D; Chrousos GP; Dichtchekenian V; Manna TD; Filho VO; Setian N
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2993-6. PubMed ID: 11443157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis.
    Fiad TM; Kirby JM; Cunningham SK; McKenna TJ
    Clin Endocrinol (Oxf); 1994 May; 40(5):603-9. PubMed ID: 8013141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus.
    Kinsley BT; Simonson DC
    J Clin Endocrinol Metab; 1996 Feb; 81(2):684-91. PubMed ID: 8636289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stimulatory effect of canrenoate, a mineralocorticoid antagonist, on the activity of the hypothalamus-pituitary-adrenal axis is abolished by alprazolam, a benzodiazepine, in humans.
    Grottoli S; Giordano R; Maccagno B; Pellegrino M; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4616-20. PubMed ID: 12364444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic-pituitary-adrenal axis following glucocorticoid prophylaxis against acute mountain sickness.
    Basu M; Sawhney RC; Kumar S; Pal K; Prasad R; Selvamurthy W
    Horm Metab Res; 2002 Jun; 34(6):318-24. PubMed ID: 12173072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary-adrenal dynamics after ACTH-secreting pituitary tumor resection in patients receiving no steroids post-operatively.
    Pimentel-Filho FR; Silva ME; Nogueira KC; Berger K; Cukiert A; Liberman B
    J Endocrinol Invest; 2005 Jun; 28(6):502-8. PubMed ID: 16117190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of the 30-minute adrenocorticotropin (ACTH) test in demonstrating hypothalamic-pituitary-adrenocortical insufficiency after acute ACTH deprivation.
    Hjortrup A; Kehlet H; Lindholm J; Stentoft P
    J Clin Endocrinol Metab; 1983 Sep; 57(3):668-70. PubMed ID: 6308036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confirmation that offspring from families with alcohol-dependent individuals have greater hypothalamic-pituitary-adrenal axis activation induced by naloxone compared with offspring without a family history of alcohol dependence.
    Wand G; McCaul ME; Gotjen D; Reynolds J; Lee S
    Alcohol Clin Exp Res; 2001 Aug; 25(8):1134-9. PubMed ID: 11505044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metyrapone test with adrenocorticotrophic levels. Separating primary from secondary adrenal insufficiency.
    Dolman LI; Nolan G; Jubiz W
    JAMA; 1979 Mar; 241(12):1251-3. PubMed ID: 216821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sodium valproate on naloxone-stimulated ACTH and cortisol release in humans.
    Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
    Clin Exp Pharmacol Physiol; 1995; 22(6-7):441-3. PubMed ID: 8582096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome.
    Calis M; Gökçe C; Ates F; Ulker S; Izgi HB; Demir H; Kirnap M; Sofuoglu S; Durak AC; Tutus A; Kelestimur F
    J Endocrinol Invest; 2004 Jan; 27(1):42-6. PubMed ID: 15053242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The low dose ACTH stimulation test is less sensitive than the overnight metyrapone test for the diagnosis of secondary hypoadrenalism.
    Soule S; Van Zyl Smit C; Parolis G; Attenborough S; Peter D; Kinvig S; Kinvig T; Coetzer E
    Clin Endocrinol (Oxf); 2000 Aug; 53(2):221-7. PubMed ID: 10931104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamus-pituitary-adrenal axis in central diabetes insipidus: ACTH and cortisol responsiveness to CRH administration.
    Pivonello R; Faggiano A; Filippella M; Di Somma C; De Martino MC; Gaccione M; Lombardi G; Colao A
    J Endocrinol Invest; 2002 Dec; 25(11):932-7. PubMed ID: 12553551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased hypothalamic-pituitary-adrenal axis sensitivity to cortisol feedback inhibition in human aging.
    Wilkinson CW; Peskind ER; Raskind MA
    Neuroendocrinology; 1997 Jan; 65(1):79-90. PubMed ID: 9032777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of indomethacin on the hypothalamic-pituitary-adrenal axis in man.
    Beirne J; Jubiz W
    J Clin Endocrinol Metab; 1978 Oct; 47(4):713-6. PubMed ID: 233680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.